PL2612677T3 - Preparat zawierający insulinę, nikotynamid i argininę - Google Patents

Preparat zawierający insulinę, nikotynamid i argininę

Info

Publication number: PL2612677T3
Authority: PL; Poland
Prior art keywords: nicotinamide; insulin; arginine; preparation
Prior art date: 2009-06-26

Application number

PL13158960T

Other languages

English (en)

Inventor

Helle Birk Olsen

Svend Havelund

Ulla Ribel-Madsen

Jeppe Sturis

Helle Naver

Morten Schlein

Svend Ludvigsen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-26

Filing date

2010-06-25

Publication date

2015-10-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41351568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2612677(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-25 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2015-10-30 Publication of PL2612677T3 publication Critical patent/PL2612677T3/pl

Links

DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
239000004475 Arginine Substances 0.000 title 1
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
229960003121 arginine Drugs 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
229960003966 nicotinamide Drugs 0.000 title 1
235000005152 nicotinamide Nutrition 0.000 title 1
239000011570 nicotinamide Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

PL13158960T 2009-06-26 2010-06-25 Preparat zawierający insulinę, nikotynamid i argininę PL2612677T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP09163940		2009-06-26
US22216809P	2009-07-01	2009-07-01
EP20130158960 EP2612677B1 (en)	2009-06-26	2010-06-25	Preparation comprising insulin, nicotinamide and arginine
EP10730134.3A EP2340033B1 (en)	2009-06-26	2010-06-25	PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND Arginine

Publications (1)

Publication Number	Publication Date
PL2612677T3 true PL2612677T3 (pl)	2015-10-30

Family

ID=41351568

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10730134T PL2340033T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę
PL13158960T PL2612677T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL10730134T PL2340033T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę

Country Status (20)

Country	Link
US (4)	US8324157B2 (pl)
EP (2)	EP2612677B1 (pl)
JP (2)	JP5669834B2 (pl)
KR (1)	KR101775000B1 (pl)
CN (2)	CN102470165B (pl)
AU (1)	AU2010264636B2 (pl)
BR (1)	BRPI1014760B8 (pl)
CA (1)	CA2764423A1 (pl)
DK (2)	DK2612677T3 (pl)
ES (2)	ES2543705T3 (pl)
HU (2)	HUE027239T2 (pl)
IL (1)	IL216520A (pl)
MX (1)	MX2011012764A (pl)
NO (1)	NO2017031I1 (pl)
PL (2)	PL2340033T3 (pl)
PT (2)	PT2612677E (pl)
RU (1)	RU2533217C3 (pl)
TW (1)	TWI459962B (pl)
WO (1)	WO2010149772A1 (pl)
ZA (1)	ZA201108942B (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9060927B2 (en)	2009-03-03	2015-06-23	Biodel Inc.	Insulin formulations for rapid uptake
US9018190B2 (en)	2009-03-27	2015-04-28	Adocia	Functionalized oligosaccharides
FR2943538B1 (fr)	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
ES2543705T3 (es) *	2009-06-26	2015-08-21	Novo Nordisk A/S	Preparación que contiene insulina, nicotinamida y arginina
KR20140030125A (ko) *	2010-12-14	2014-03-11	노보 노르디스크 에이/에스	인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
US9993529B2 (en)	2011-06-17	2018-06-12	Halozyme, Inc.	Stable formulations of a hyaluronan-degrading enzyme
GB201113880D0 (en) *	2011-08-12	2011-09-28	Archimed Llp	Novel compositions
US20130231281A1 (en)	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
SG11201403714TA (en)	2011-12-30	2014-07-30	Halozyme Inc	Ph20 polypeptide variants, formulations and uses thereof
WO2013186138A1 (en) *	2012-06-14	2013-12-19	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and arginine
EP2919804B1 (fr)	2012-11-13	2018-01-31	Adocia	Formulation à action rapide d'insuline comprenant un composé anionique substitué
MX360420B (es)	2012-12-19	2018-10-31	Wockhardt Ltd	Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
TWI780236B (zh) *	2013-02-04	2022-10-11	法商賽諾菲公司	胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
PT2950780T (pt) *	2013-02-04	2020-07-07	Sanofi Sa	Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina
TW201534726A (zh)	2013-07-03	2015-09-16	Halozyme Inc	熱穩定ｐｈ２０玻尿酸酶變異體及其用途
JP6641280B2 (ja)	2014-01-09	2020-02-05	サノフイＳａｎｏｆｉ	インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤
WO2015120457A1 (en) *	2014-02-10	2015-08-13	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations
WO2015131902A1 (en) *	2014-03-07	2015-09-11	Jørgensen Klavs Holger	Novel fast acting insulin preparations
TWI685348B (zh) *	2014-05-08	2020-02-21	美國禮來大藥廠	速效胰島素組合物
FR3020947B1 (fr)	2014-05-14	2018-08-31	Adocia	Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en)	2014-05-14	2017-10-24	Adocia	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
AR102869A1 (es)	2014-12-16	2017-03-29	Lilly Co Eli	Composiciones de insulina de rápida acción
US20180221385A1 (en)	2015-07-28	2018-08-09	Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et	A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (ar)	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr)	2015-11-16	2019-05-31	Adocia	Composition a action rapide d'insuline comprenant un citrate substitue
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
GB201613895D0 (en)	2016-08-12	2016-09-28	Arecor Ltd	Novel composition
EP4265296A3 (en)	2016-09-29	2023-12-20	Arecor Limited	Pharmaceutical formulation comprising an insulin compound
GB201707187D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707189D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707188D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
EP3773473B1 (en)	2018-04-04	2026-07-01	Arecor Limited	MEDICAL INFUSION PUMP SYSTEM FOR ADMINISTRATING AN INSULIN COMPOUND
EP3773474B1 (en)	2018-04-04	2026-01-07	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
JP7465813B2 (ja)	2018-04-04	2024-04-11	アレコルリミテッド	インスリン化合物の送達のための医療用注入ポンプシステム
FR3083984A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
CN112739679B (zh)	2018-09-18	2024-03-12	伊莱利利公司	曲前列环素的特丁胺盐
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations
AR131148A1 (es)	2022-11-26	2025-02-19	Obshchestvo S Ogranichennoy Otvetstvennostyu «Geropharm»	Composiciones de insulina de acción rápida (variantes de las mismas)
WO2024123214A1 (ru)	2022-12-04	2024-06-13	Общество С Ограниченной Ответственностью "Герофарм"	Композиция инсулина аспарта (варианты)
TW202521158A (zh) *	2023-11-17	2025-06-01	大陸商上海藥明生物技術有限公司	用於高濃度蛋白製劑的降黏穩定製劑

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4205126A (en) *	1978-01-01	1980-05-27	Cartaya Oscar A	Serum-free cell culture media
NZ199391A (en)	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
ZA827928B (en) *	1981-10-30	1983-08-31	Novo Industri As	Stabilized insulin preparations and process for preparation thereof
DE3313386A1 (de) *	1983-04-13	1984-10-18	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München	Verfahren zur herstellung von nicht-brennbaren, thermisch isolierenden formkoerpern aus geblaehtem perlit
DK58285D0 (da)	1984-05-30	1985-02-08	Novo Industri As	Peptider samt fremstilling og anvendelse deraf
DK336188D0 (da)	1988-06-20	1988-06-20	Nordisk Gentofte	Propeptider
DK105489D0 (da)	1989-03-03	1989-03-03	Novo Nordisk As	Polypeptid
US5382574A (en)	1989-12-21	1995-01-17	Novo Nordisk A/S	Insulin preparations containing nicotinic acid or nicotinamide
WO1995016708A1 (en)	1993-12-17	1995-06-22	Novo Nordisk A/S	Proinsulin-like compounds
RU2175556C2 (ru) *	1994-03-07	2001-11-10	Инхейл Терапьютик Системз	Способы и композиции для легочной доставки инсулина
US6500645B1 (en)	1994-06-17	2002-12-31	Novo Nordisk A/S	N-terminally extended proteins expressed in yeast
ZA954983B (en)	1994-06-17	1996-02-14	Novo Nordisk As	N-terminally extended proteins expressed in yeast
WO1996010417A1 (en) *	1994-10-04	1996-04-11	Novo Nordisk A/S	PREPARATIONS CONTAINING AspB28 HUMAN INSULIN AND NICOTINAMIDE
KR0150565B1 (ko)	1995-02-15	1998-08-17	김정재	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
IL118127A0 (en)	1995-05-05	1996-09-12	Lilly Co Eli	Single chain insulin with high bioactivity
US6043092A (en) *	1996-03-18	2000-03-28	University Of Pittsburgh	Cell culture media for mammalian cells
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
AR012894A1 (es) *	1997-06-13	2000-11-22	Lilly Co Eli	Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
DK1283051T3 (da) *	1997-06-13	2006-10-16	Lilly Co Eli	Stabile insulinformuleringer
US6734162B2 (en) *	2000-01-24	2004-05-11	Minimed Inc.	Mixed buffer system for stabilizing polypeptide formulations
US6573237B2 (en)	2001-03-16	2003-06-03	Eli Lilly And Company	Protein formulations
DE10114178A1 (de) *	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
WO2003020201A2 (en) *	2001-08-28	2003-03-13	Eli Lilly And Company	Pre-mixes of glp-1 and basal insulin
US7115563B2 (en)	2002-05-29	2006-10-03	Insignion Holding Limited	Composition and its therapeutic use
US20050232974A1 (en)	2004-04-19	2005-10-20	Gore Makarand P	System and a method for pharmaceutical dosage preparation using jettable microemulsions
WO2007121256A2 (en)	2006-04-12	2007-10-25	Biodel, Inc.	Rapid acting and long acting insulin combination formulations
CN101541830A (zh)	2006-09-22	2009-09-23	诺沃-诺迪斯克有限公司	蛋白酶抗性的胰岛素类似物
WO2008037735A1 (en)	2006-09-27	2008-04-03	Novo Nordisk A/S	Method for making maturated insulin polypeptides
CA2673054C (en)	2006-12-15	2016-05-10	Tima Foundation	Novel compositions and uses thereof
US8575096B2 (en) *	2007-08-13	2013-11-05	Novo Nordisk A/S	Rapid acting insulin analogues
ES2543705T3 (es) *	2009-06-26	2015-08-21	Novo Nordisk A/S	Preparación que contiene insulina, nicotinamida y arginina

2010
- 2010-06-25 ES ES13158960.8T patent/ES2543705T3/es active Active
- 2010-06-25 CA CA2764423A patent/CA2764423A1/en not_active Withdrawn
- 2010-06-25 RU RU2012100397A patent/RU2533217C3/ru active Protection Beyond IP Right Term
- 2010-06-25 PL PL10730134T patent/PL2340033T3/pl unknown
- 2010-06-25 EP EP20130158960 patent/EP2612677B1/en active Active
- 2010-06-25 JP JP2012516763A patent/JP5669834B2/ja active Active
- 2010-06-25 DK DK13158960.8T patent/DK2612677T3/en active
- 2010-06-25 BR BRPI1014760A patent/BRPI1014760B8/pt active IP Right Grant
- 2010-06-25 DK DK10730134.3T patent/DK2340033T3/da active
- 2010-06-25 MX MX2011012764A patent/MX2011012764A/es active IP Right Grant
- 2010-06-25 ES ES10730134.3T patent/ES2440289T3/es active Active
- 2010-06-25 PT PT131589608T patent/PT2612677E/pt unknown
- 2010-06-25 PT PT107301343T patent/PT2340033E/pt unknown
- 2010-06-25 KR KR1020127000115A patent/KR101775000B1/ko active Active
- 2010-06-25 EP EP10730134.3A patent/EP2340033B1/en active Active
- 2010-06-25 CN CN201080029548.9A patent/CN102470165B/zh active Active
- 2010-06-25 AU AU2010264636A patent/AU2010264636B2/en active Active
- 2010-06-25 HU HUE13158960A patent/HUE027239T2/en unknown
- 2010-06-25 PL PL13158960T patent/PL2612677T3/pl unknown
- 2010-06-25 CN CN201410659076.5A patent/CN104667264B/zh active Active
- 2010-06-25 WO PCT/EP2010/059069 patent/WO2010149772A1/en not_active Ceased
- 2010-06-28 TW TW099121012A patent/TWI459962B/zh active
2011
- 2011-11-22 IL IL216520A patent/IL216520A/en active IP Right Grant
- 2011-12-01 US US13/309,134 patent/US8324157B2/en active Active
- 2011-12-06 ZA ZA2011/08942A patent/ZA201108942B/en unknown
2012
- 2012-11-07 US US13/671,034 patent/US20130281364A1/en not_active Abandoned
2014
- 2014-03-24 US US14/223,408 patent/US20140206610A1/en not_active Abandoned
- 2014-11-04 JP JP2014223915A patent/JP6026485B2/ja active Active
2015
- 2015-03-16 US US14/658,358 patent/US20150182595A1/en not_active Abandoned
2017
- 2017-06-06 HU HUS1700027C patent/HUS1700027I1/hu unknown
- 2017-07-06 NO NO2017031C patent/NO2017031I1/no unknown

Also Published As

Publication number	Publication date
JP6026485B2 (ja)	2016-11-16
ZA201108942B (en)	2012-08-29
US20130281364A1 (en)	2013-10-24
WO2010149772A1 (en)	2010-12-29
DK2340033T3 (da)	2014-01-20
PT2340033E (pt)	2014-02-04
AU2010264636B2 (en)	2013-06-27
TW201100093A (en)	2011-01-01
IL216520A0 (en)	2012-02-29
ES2440289T3 (es)	2014-01-28
CN102470165A (zh)	2012-05-23
PL2340033T3 (pl)	2014-03-31
JP2015071608A (ja)	2015-04-16
IL216520A (en)	2017-08-31
EP2612677A1 (en)	2013-07-10
KR101775000B1 (ko)	2017-09-04
TWI459962B (zh)	2014-11-11
PT2612677E (pt)	2015-09-10
BRPI1014760A2 (pt)	2017-07-18
CN102470165B (zh)	2014-12-24
BRPI1014760B8 (pt)	2021-05-25
MX2011012764A (es)	2012-01-20
NO2017031I1 (no)	2017-07-06
US20150182595A1 (en)	2015-07-02
US20120135920A1 (en)	2012-05-31
EP2340033B1 (en)	2013-10-09
BRPI1014760B1 (pt)	2021-04-13
JP2012530768A (ja)	2012-12-06
RU2012100397A (ru)	2013-08-10
DK2612677T3 (en)	2015-07-27
CN104667264B (zh)	2018-09-07
RU2533217C2 (ru)	2014-11-20
US20140206610A1 (en)	2014-07-24
EP2612677B1 (en)	2015-05-06
HUS1700027I1 (hu)	2017-07-28
CN104667264A (zh)	2015-06-03
KR20120047226A (ko)	2012-05-11
RU2533217C3 (ru)	2020-12-21
ES2543705T3 (es)	2015-08-21
CA2764423A1 (en)	2010-12-29
HUE027239T2 (en)	2016-10-28
AU2010264636A1 (en)	2012-01-12
JP5669834B2 (ja)	2015-02-18
US8324157B2 (en)	2012-12-04
BRPI1014760A8 (pt)	2018-01-09
EP2340033A1 (en)	2011-07-06

Publication	Publication Date	Title
HUS1700027I1 (hu)	2017-07-28	Inzulint, nikotinamidot és arginint tartalmazó készítmény
IL222930A0 (en)	2012-12-31	Chlorotoxin variants, conjugates and methods for their use
EP2590653A4 (en)	2014-01-01	5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE, SALT THEREOF AND APPLICATIONS THEREOF
EP2481739A4 (en)	2013-02-27	DIHYDROPTERIDINONE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL USE
EP2530079A4 (en)	2013-06-19	PHENYL-C-GLUCOSIDE DERIVATIVES, PREPARATION METHODS AND USES THEREOF
IL218490A0 (en)	2012-04-30	Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
PT2655375E (pt)	2015-03-02	Derivados de pirimidinona, sua preparação e sua utilização farmacêutica
IL215684A0 (en)	2012-01-31	Trehalulose-containing composition, its preparation and use
ZA201209595B (en)	2014-03-26	N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
IL226336A0 (en)	2013-07-31	A preparation containing insulin, nicotinamide and amino acid
IL224472A (en)	2016-12-29	Fibrin base scaffold, its use and manner of preparation
IL219888A0 (en)	2012-07-31	Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
ZA201406382B (en)	2015-12-23	Levoisovalerylspiramycin i,ii,iii and preparations ,preparation methods and uses thereof
SG10201606838VA (en)	2016-09-29	Infusion preparation
ZA201206740B (en)	2013-06-26	Aildenafil citrate crystal form o,preparation method and use thereof
IL226108A0 (en)	2013-06-27	Highly efficient catalysts, their preparation and use
SI2421864T1 (sl)	2014-11-28	1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
IL214544A0 (en)	2011-09-27	Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
EP2621490A4 (en)	2014-04-02	PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
EP2573067A4 (en)	2014-10-29	AROMATIC BUTANE-2-OL COMPOUNDS AND MANUFACTURING METHOD AND USES THEREOF
AP2012006129A0 (en)	2012-02-29	Benzamide derivatives, preparation and use thereof.
IL220859A0 (en)	2012-09-24	Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application
GB201000148D0 (en)	2010-02-24	Article, its manufacture and use
GB0902875D0 (en)	2009-04-08	Medicaments,uses and methods
GB0900129D0 (en)	2009-02-11	Article, its manufacture and use